Common risk factors for heart failure and cancer
WC Meijers, RA de Boer - Cardiovascular research, 2019 - academic.oup.com
Cardiovascular (CV) disease and cancer are the leading causes of death., Over the last
decades, it has been appreciated that both CV disease and cancer are more common in …
decades, it has been appreciated that both CV disease and cancer are more common in …
Meta-analysis: β-blocker dose, heart rate reduction, and death in patients with heart failure
FA McAlister, N Wiebe, JA Ezekowitz… - Annals of Internal …, 2009 - acpjournals.org
Background: Guidelines recommend that patients with heart failure receive β-blockers in
doses used in the trials that have proven their efficacy. Although the adverse effects of β …
doses used in the trials that have proven their efficacy. Although the adverse effects of β …
[HTML][HTML] Diretrizes brasileiras de hipertensão arterial–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
A hipertensão arterial (HA) é uma doença crônica não transmissível (DCNT) definida por
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …
Brazilian guidelines of hypertension–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
SciELO - Brasil - Diretrizes Brasileiras de Hipertensão Arterial – 2020 Diretrizes Brasileiras de
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
RR van Kimmenade, JL Januzzi, PT Ellinor… - Journal of the American …, 2006 - jacc.org
Objectives: This study sought to explore the role of new biomarkers in heart failure (HF).
Background: We investigated the utility of novel serum markers alone or together with …
Background: We investigated the utility of novel serum markers alone or together with …
Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD
AD Sinha, R Agarwal - Clinical Journal of the American Society of …, 2019 - journals.lww.com
CKD is common and frequently complicated with hypertension both predialysis and in
ESKD. As a major modifiable risk factor for cardiovascular disease in this high-risk …
ESKD. As a major modifiable risk factor for cardiovascular disease in this high-risk …
III Diretriz brasileira de insuficiência cardíaca crônica
EA Bocchi, FGM Braga, SMA Ferreira… - Arquivos Brasileiros …, 2009 - SciELO Brasil
O objetivo desta Diretriz é servir de apoio e auxiliar os médicos nas decisões referentes aos
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …
Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity
N Smart, TH Marwick - The American journal of medicine, 2004 - Elsevier
PURPOSE: To determine the efficacy of exercise training and its effects on outcomes in
patients with heart failure. METHODS: MEDLINE, Medscape, and the Cochrane Controlled …
patients with heart failure. METHODS: MEDLINE, Medscape, and the Cochrane Controlled …
Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance
TD O'Connell, BC Jensen, AJ Baker… - Pharmacological reviews, 2014 - ASPET
Adrenergic receptors (AR) are G-protein-coupled receptors (GPCRs) that have a crucial role
in cardiac physiology in health and disease. Alpha1-ARs signal through G α q, and signaling …
in cardiac physiology in health and disease. Alpha1-ARs signal through G α q, and signaling …
Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release
Q Zhou, J Xiao, D Jiang, R Wang, K Vembaiyan… - Nature medicine, 2011 - nature.com
Carvedilol is one of the most effective beta blockers for preventing ventricular
tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic …
tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic …